Table 2. JBI Quality appraisal checklist for all included studies of GMP service utilization among children less than two years in Ethiopia, 2023.

Included studies		JBI Critical Appraisal Checklist for Cross Sectional Studies(Yes, No, Unclear)
		If Yes(>=50%).....low risk(two raters).....1=Yes 2=No 3=Unclear
		Appropriate Inclusion criteria				Description of study subject and setting			Valid and reliable measurement of exposure				Objective and standard criteria used				Identification of confounder				Strategies to handle confounder				Appropriate Outcome measurement					Appropriate statistical analysis				Over all appraisal
		R1		R2		R1	R2		R 1		R2		R1	R2			R 1		R2		R 1		R2		R 1			R2		R1		R2
1.Yeshaneh et al		1		1		1	1		1		2		2	2			1		1		1		1		1			1		1		1		0.8125
2.Tufa et al		1		1		1	1		1		1		1	1			1		1		1		1		1			1		2		2		0.875
3.Kiros et al		1		1		1	1		1		1		1	1			2		2		2		1		1			1		1		1		0.8125
4.Girma et al		1		1		1	1		1		1		1	1			2		2		2		1		1			1		1		1		0.8125
5.Feleke et al		1		2		1	1		1		1		1	1			1		1		1		1		1			1		1		1		0.9375
6.Endale et al		2		2		1	1		1		1		1	1			1		1		1		1		1			1		1		1		0.875
JBI Quality appraisal of included case-control study for growth monitoring and promotion service utilization in Ethiopia, 2023
If Yes(> = 50%)…‥low risk(two raters)…‥>1 = Yes 2 = No 3 = Unclear
Included study	Group comparable among presence of disease in case and absence of disease in control				Case and control matched appropriately			Similar criteria used for case and control				Standard exposure measurement				Similar exposure measurement for case and control				Identify confounding factor				Strategies deal with confounding factor stated			Standard outcome measurement for case and control				Long period of interest for exposure			Appropriate statistical analysis			Over all appraisal
	R1		R2		R1		R2	R1		R2		R1			R2	R1		R2		R1		R2		R1		R2	R1		R2		R1		R2		R1	R2
7.Dagne et al	1		2		1		1	1		1		1			1	1		1		1		1		3		1	1		1		1		1		2	1	0.85

Footnote, R1; Researcher 1, R2; Researcher 2